Norwegian version of this page

@IR-FGS Evidence-Based Lesion Recognition App for Diagnosing Female Genital Schistosomiasis

Duration
–
Project type
Innovation project

The @IR-FGS project aims to develop and commercialize a mobile application to improve diagnosis and training for female genital schistosomiasis (FGS). This disease, a neglected tropical disease related to poverty, affects over 56 million women and girls, primarily in Sub-Saharan Africa. Misdiagnosis of FGS often occurs due to symptoms that resemble those of sexually transmitted infections and cervical cancer, which can lead to stigma and inappropriate treatment.

Contact persons

Project description

The app combines machine learning and spectral images to assist with lesion recognition instruction through advanced diagnostic training. It is specifically designed for use in resource-limited environments and by healthcare professionals with limited access to traditional diagnostic tools. The project is built on a unique database of 24,000 clinically assessed images, supported by research from the European Research Council-funded DUALSAVE-FGS project and the World Health Organization (WHO).

The primary goals are to transition the app from the prototype stage (TRL 4) to operational deployment (TRL 7), validate its diagnostic accuracy, and implement it in healthcare institutions in Norway, South Africa, and Uganda. Further objectives include training healthcare workers, establishing a fair and sustainable business model, and contributing to the UN Sustainable Development Goal 3 for good health and well-being as well as WHO's Universal Health Coverage (UHC). This should ensure everyone has access to quality essential health services without financial hardship.

Research and development challenges include ensuring diagnostic precision across diverse clinical environments, achieving user acceptance, and integrating the app into existing health systems. The project employs interdisciplinary approaches, combining digital health, public health, machine learning, and clinical research to tackle these challenges.

Participants

Funding

Funded by The Research Council of Norway

Project number: 360341

Published Sep. 5, 2025 1:51 PM - Last modified Sep. 5, 2025 1:51 PM